Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
36 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Transition Therapeutics Inc. (Transition) is a biopharmaceutical company that develops medicines for the treatment of CNS disorders, Alzheimers disease and diabetes. The company is developing drugs for the treatment of aggression associated with Down syndrome and Alzheimer's disease. It is also developing a metabolic drug candidate for the treatment of type two diabetes and accompanying obesity. Transition is also currently conducting clinical trials on several upcoming drugs for the treatment of various diseases. It partners with various other biopharmaceutical companies to market its products.Transition is headquartered in Toronto, Ontario, Canada.

Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company<

  
Source:
Document ID
GDPH82065D
Country
Industry
Ticker
TTH=CA
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Transition Therapeutics Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Transition Therapeutics Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Transition Therapeutics Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Transition Therapeutics Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Transition Therapeutics Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Transition Therapeutics Inc., Pharmaceuticals &Healthcare, Deal Details1122
  Partnerships111
    Transition Therapeutics Enters into Agreement with Brigham and Women's Hospital111
    Perrigo Amends Development And Commercialization Agreement With Transition Therapeutics For ELND005122
    Elan Corporation Amends Its Collaboration With Transition Therapeutics141
  Licensing Agreements151
    Transition Therapeutics Enters into Licensing Agreement with Eli Lilly for TT701151
    Transition Therapeutics Enters Into Licensing Agreement With Eli Lilly For TT-601162
    Transition Therapeutics and Eli Lilly Amend Licensing Agreement182
    Transition Therapeutics Enters Into Licensing Agreement With Eli Lilly202
  Equity Offering221
    Transition Therapeutics Raises USD23 Million in Public Offering of Shares222
    Transition Therapeutics Raises USD17 Million in Private Placement of Units242
    Transition Therapeutics Completes Private Placement Of Shares For US$11 Million262
    Transition Therapeutics Completes Non-Brokered Private Placement Of Shares For US$5 Million282
  Acquisition301
    OPKO Health Acquires Transition Therapeutics for USD60 Million302
    Perrigo To Acquire 7% Stake In Transition Therapeutics For US$15 Million321
Transition Therapeutics Inc. - Key Competitors331
Key Employees341
Locations And Subsidiaries351
  Head Office351
  Other Locations &Subsidiaries351
Appendix361
  Methodology361
  About GlobalData361
  Contact Us361
  Disclaimer361

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Transition-Therapeutics-Inc-TTH-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7704>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Transition Therapeutics Inc. (TTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Transition-Therapeutics-Inc-TTH-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7704>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research